Consistent, with the lack of changes in β-F1-ATPase expression in adenocarcinomas its T/NAT ratio remained unaltered whereas the T/NAT ratios of IF1, or of any of the biomarkers already mentioned (RoB), sharply increased (Fig. 2c). Here, BRD2 is linked to adenocarcinoma.